Controls that received the same dose of a closely related but inactive analogue, MCP-1Ala, developed similar swelling to that of untreated controls, but showed a trend towards a delayed onset.
← all excerpts
An antagonist of monocyte chemoattractant protein 1 (MCP-1) inhibits arthritis in the MRL-lpr mouse model.
1
—
—